Osseointegration of anodized titanium implants coated with fibroblast growth factor-fibronectin (FGF-FN) fusion protein.
The synergistic effect of fibroblast growth factor (FGF) and human fibronectin fragment (hFNIII9-10) on osteoblast cell adhesion has been demonstrated in vitro. The purpose of this study was to evaluate the bone response around anodized titanium implants treated with FGF-FN fusion protein using the histomorphometric analysis and the removal torque test. Threaded implants were manufactured by machining a commercially pure titanium (grade 4). Two different groups of samples were prepared: Group 1 samples were anodized under a constant voltage of 300 V, and group 2 samples were anodized under a constant voltage of 300 V and then soaked in a solution containing fusion protein (65 microg/mL) for 24 hours. Ten implants from each group were placed in rabbit tibiae (1 implant per group per rabbit; each rabbit served as its own control). After a 3-month healing period, the animals were sacrificed. Removal torque testing and histomorphometric analysis was then carried out. The mean removal torque value of group 2 (44.8 Ncm) was greater than that of group 1 (37.6 Ncm). The percentages of bone-implant contact of the best 3 consecutive threads were 76.37% for group 1 and 88.02% for group 2. The percentage of bone-implant contact for the total length of the implant was higher for group 2 (36.91%) than for group 1 (29.47%). However, the percentage of the area inside the threads that consisted of bone did not differ significantly for the 2 groups. This study demonstrated that the FGF-FN fusion protein coating on anodized implants may enhance osseointegration. However, the influence of fibronectin- and FGF-treated rough surfaces on long-term prognosis and the propagation of inflammation are subjects for further study.